Natalizumab Changes the Peripheral Profile of the Th17 Panel in MS Patients: New Mechanisms of Action-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Natalizumab Changes the Peripheral Profile of the Th17 Panel in MS Patients: New Mechanisms of Action

Published:2018-01-19 Issue:9 Volume:16 Page:
ISSN:1871-5273
Container-title:CNS & Neurological Disorders - Drug Targets
language:en
Short-container-title:CNSNDDT

Author:

Balasa Rodica Ioana¹,Simu Mihaela²,Voidazan Septimiu³,Barcutean Laura Iulia⁴,Bajko Zoltan¹,Hutanu Adina⁵,Simu Iunius⁶,Maier Smaranda¹

Affiliation:

1. Department of Neurology, University of Medicine and Pharmacy Targu Mures, Mures County Clinical Emergency Hospital, Targu Mures, Romania

2. UMF “Victor Babes”, ”Pius Brinzeu” County Emergency Clinical Hospital, Department of Neurology, Timisoara, Romania

3. Romania Department of Epidemiology, University of Medicine and Pharmacy Targu Mures, Targu Mures, Romania

4. Department of Neurology, Mures County Clinical Emergency Hospital, Targu Mures, Romania

5. Department of Laboratory Medicine, CCAMF, University of Medicine and Pharmacy Targu Mures, Targu Mures, Romania

6. Department of Radiology, University of Medicine and Pharmacy Targu Mures, Mures County Clinical Emergency Hospital, Targu Mures, Romania

Publisher

Bentham Science Publishers Ltd.

Subject

Pharmacology,General Neuroscience

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advances in immune checkpoint-based immunotherapies for multiple sclerosis: rationale and practice;Cell Communication and Signaling;2023-11-09

2. Histamine H4 Receptor Antagonist Ameliorates the Progression of Experimental Autoimmune Encephalomyelitis via Regulation of T-Cell Imbalance;International Journal of Molecular Sciences;2023-10-17

3. The peripheral profile of the chitinase 3-like-1 in benign multiple sclerosis – a single centre’s experience;CNS & Neurological Disorders - Drug Targets;2023-06-09

4. Interleukin-31 and soluble CD40L: new candidate serum biomarkers that predict therapeutic response in multiple sclerosis;Neurological Sciences;2022-07-18

5. Characterization of immune profile in an aging multiple sclerosis clinic population;Multiple Sclerosis and Related Disorders;2022-07

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3